Literature DB >> 16186240

Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus.

John R White1, Victoria Boyd1, Gary S Crameri1, Christine J Duch1, Ryan K van Laar1, Lin-Fa Wang1, Bryan T Eaton1.   

Abstract

Epitopes involved in a protective immune response to Hendra virus (HeV) (Henipavirus, Paramxyoviridae) were investigated by generating five neutralizing monoclonal antibodies (mAbs) to the virus attachment protein (G) of HeV (HeV G) and sequencing of the G gene of groups of neutralization-escape variants selected with each mAb. Amino acid substitutions occurred at eight distinct sites on HeV G. Relationships between these sites were investigated in binding and neutralization assays using heterologous combinations of variants and mAbs. The sites were also mapped to a proposed structural model for the attachment proteins of Paramyxoviridae. Their specific locations and the nature of their interactions with the mAb panel provided the first functional evidence that HeV G in fact resembled the proposed structure. Four sites (aa 183-185, 417, 447 and 570) contributed to a major discontinuous epitope, on the base of the globular head, that was similar to immunodominant virus neutralization sites found in other paramyxoviruses. Amino acid similarity between HeV and Nipah virus was relatively highly conserved at these sites but decreased significantly at the other sites identified in this study. These included another discontinuous epitope on the base of the head region defined by sites aa 289 and 324 and well separated epitopes on the top of the head at sites aa 191-195 and 385-356. The latter epitope corresponded to immunodominant neutralization sites found in Rinderpest virus and Measles virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186240     DOI: 10.1099/vir.0.81218-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.

Authors:  Kimberly A Bishop; Tzanko S Stantchev; Andrew C Hickey; Dimple Khetawat; Katharine N Bossart; Valery Krasnoperov; Parkash Gill; Yan Ru Feng; Lemin Wang; Bryan T Eaton; Lin-Fa Wang; Christopher C Broder
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.

Authors:  Birgit G Bradel-Tretheway; Qian Liu; Jacquelyn A Stone; Samantha McInally; Hector C Aguilar
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

Review 4.  Immunization strategies against henipaviruses.

Authors:  Christopher C Broder; Thomas W Geisbert; Kai Xu; Dimitar B Nikolov; Lin-Fa Wang; Deborah Middleton; Jackie Pallister; Katharine N Bossart
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model.

Authors:  Vanessa Guillaume; Hamide Aslan; Michelle Ainouze; Mathilde Guerbois; T Fabian Wild; Robin Buckland; Johannes P M Langedijk
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.

Authors:  Kimberly A Bishop; Andrew C Hickey; Dimple Khetawat; Jared R Patch; Katharine N Bossart; Zhongyu Zhu; Lin-Fa Wang; Dimiter S Dimitrov; Christopher C Broder
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

7.  Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Authors:  Oscar A Negrete; David Chu; Hector C Aguilar; Benhur Lee
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

8.  Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.

Authors:  A Di Rubbo; L McNabb; R Klein; J R White; A Colling; D S Dimitrov; C C Broder; D Middleton; R A Lunt
Journal:  J Virol Methods       Date:  2019-09-09       Impact factor: 2.014

9.  Detailed morphological characterisation of Hendra virus infection of different cell types using super-resolution and conventional imaging.

Authors:  Paul Monaghan; Diane Green; Jackie Pallister; Reuben Klein; John White; Catherine Williams; Paul McMillan; Leann Tilley; Marko Lampe; Pippa Hawes; Lin-Fa Wang
Journal:  Virol J       Date:  2014-11-27       Impact factor: 4.099

10.  A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.

Authors:  Pramila Walpita; Yu Cong; Peter B Jahrling; Oscar Rojas; Elena Postnikova; Shuiqing Yu; Lisa Johns; Michael R Holbrook
Journal:  NPJ Vaccines       Date:  2017-08-08       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.